Investigational Injectable Drug Demonstrates Efficacy in Localized Fat Reduction
Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.
Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.
The professional-exclusive serum and cream use epidermal growth factor and amino acids to support skin barrier repair, with small clinical studies reporting improvements in redness, hydration, and recovery following aesthetic procedures.